Corrosion Testing For Nickel Stents Front And Center In FDA Final Update
This article was originally published in The Gray Sheet
Executive Summary
The agency says it has taken into account feedback from industry during a 2013 workshop on the risks of nickel stents, and has reduced its requirements for standard corrosion testing while also outlining steps on when to adopt different corrosion testing methods.
You may also be interested in...
US FDA Gives Its Two-Cents On Nickel-Titanium Alloys
Nitinol, a nickel-titanium alloy ubiquitous in medical devices, is getting more scrutiny from US FDA in a recently released draft guidance. As safety concerns have arisen in the past few years over biocompatibility of certain materials in implanted products, the agency is asking device makers to provide additional information on nitinol in their device submissions.
Boston Sci's Innova OK'd By FDA To Treat Peripheral Artery Disease
The vascular self-expanding stent system has been approved as an advanced treatment for patients with narrowing or blockages in their superficial femoral artery or proximal popliteal artery, which can lead to peripheral artery disease – a condition that affects 8 million Americans.
FDA Offers Partial Draft Guidance On Bench Tests For Stents
CDRH has put out a short draft update on some issues related to stent material testing as it develops a major update to its guidance on nonclinical engineering tests for stents.